Techno Medical PCL (BKK:TM)

Techno Medical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	705.25	725.18	696.02	642.86	674.15	630.87
Other Revenue	0.93	0.83	0.99	2.18	1.3	0.76
Revenue	706.17	726.01	697.01	645.04	675.45	631.62
Revenue Growth (YoY)	-2.73%	4.16%	8.06%	-4.50%	6.94%	-8.42%
Cost of Revenue	454.4	492.3	465.5	414.33	418.31	383.78
Gross Profit	251.78	233.71	231.51	230.71	257.13	247.84
Selling, General & Admin	211.18	229.17	225.24	212.3	201.81	190.1
Operating Expenses	210.87	229.54	224.63	212.15	202.01	183.16
Operating Income	40.91	4.17	6.88	18.56	55.12	64.68
Interest Expense	-15.06	-19.97	-15.58	-6.27	-5.02	-7.62
Currency Exchange Gain (Loss)	-1.39	4.44	5.66	4.69	-4.91	-5.04
EBT Excluding Unusual Items	24.46	-11.36	-3.05	16.97	45.19	52.02
Asset Writedown	0	-14.94	-	-	-	-
Pretax Income	24.46	-26.3	-3.05	16.97	45.19	52.02
Income Tax Expense	10.31	4.83	8.88	5.89	15.45	11.1
Earnings From Continuing Operations	14.15	-31.14	-11.92	11.08	29.74	40.92
Minority Interest in Earnings	5.39	9.5	7.44	1.91	0.76	0.15
Net Income	19.54	-21.64	-4.49	12.99	30.5	41.07
Net Income to Common	19.54	-21.64	-4.49	12.99	30.5	41.07
Net Income Growth	-	-	-	-57.41%	-25.74%	-32.58%
Shares Outstanding (Basic)	308	308	308	308	308	309
Shares Outstanding (Diluted)	308	308	308	314	308	309
Shares Change (YoY)	-	-	-1.94%	1.98%	-0.27%	0.36%
EPS (Basic)	0.06	-0.07	-0.01	0.04	0.10	0.13
EPS (Diluted)	0.06	-0.07	-0.01	0.04	0.10	0.13
EPS Growth	-	-	-	-58.18%	-25.56%	-32.83%
Free Cash Flow	55.56	42.51	-71.97	-110.37	-48.65	3.24
Free Cash Flow Per Share	0.18	0.14	-0.23	-0.35	-0.16	0.01
Dividend Per Share	-	-	0.033	0.050	0.085	0.100
Dividend Growth	-	-	-34.00%	-41.18%	-15.00%	-23.08%
Gross Margin	35.65%	32.19%	33.21%	35.77%	38.07%	39.24%
Operating Margin	5.79%	0.57%	0.99%	2.88%	8.16%	10.24%
Profit Margin	2.77%	-2.98%	-0.64%	2.01%	4.52%	6.50%
Free Cash Flow Margin	7.87%	5.85%	-10.32%	-17.11%	-7.20%	0.51%
EBITDA	65.98	36.58	34.2	34.41	68.79	75.92
EBITDA Margin	9.34%	5.04%	4.91%	5.33%	10.18%	12.02%
D&A For EBITDA	25.07	32.42	27.32	15.85	13.67	11.24
EBIT	40.91	4.17	6.88	18.56	55.12	64.68
EBIT Margin	5.79%	0.57%	0.99%	2.88%	8.16%	10.24%
Effective Tax Rate	42.15%	-	-	34.70%	34.19%	21.34%
Revenue as Reported	704.79	730.45	702.67	649.73	670.54	631.62

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.